Interaction Checker

Interacciones de Dutasterida

Dutasterida (Avodart), inhibidor de la 5-alfa reductasa, tiene 67 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 2; moderadas: 20; leves: 35; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 10. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (2)

  • Dutasterida y tamsulosinainhibidor de la 5-alfa reductasaGrave

    Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to dutasteride or other 5 alpha-reductase inhibitors [see Adverse Reactions (6.2) ]. (etiqueta de Dutasterida, Contraindicaciones)

  • Finasteridainhibidor de la 5-alfa reductasaGrave

    Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to dutasteride or other 5 alpha-reductase inhibitors [see Adverse Reactions (6.2) ]. (etiqueta de Dutasterida, Contraindicaciones)

Interacciones moderadas (20)

  • Amlodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Amlodipino y atorvastatinabloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Amlodipino y benazeprilbloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Amlodipino y olmesartánbloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Amlodipino y valsartánbloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Digoxinaglucósido digitálicoModerada

    Digoxin Dutasteride capsules do not alter the steady-state pharmacokinetics of digoxin when administered concomitantly at a dose of 0.5 mg/day for 3 weeks [see Clinical Pharmacology (12.3) ]. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Diltiazembloqueador de los canales de calcioModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Felodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Isradipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Itraconazolantifúngico azólicoModerada

    Dutasteride Oxybutynin Sildenafil (for erectile dysfunction) Tadalafil (for erectile dysfunction and benign prostatic hyperplasia) Tolterodine Monitor for adverse reactions. (etiqueta de Itraconazol, Interacciones medicamentosas)

  • Lopinavir y ritonavirantirretroviralModerada

    Use with caution in patients taking potent, chronic cytochrome P450 (CYP)3A4 enzyme inhibitors (e.g., ritonavir). (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Nicardipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Nifedipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Nimodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Nirmatrelvir y ritonavirantiviralModerada

    Use with caution in patients taking potent, chronic cytochrome P450 (CYP)3A4 enzyme inhibitors (e.g., ritonavir). (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Nisoldipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Olmesartán, amlodipino e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • RitonavirantirretroviralModerada

    Use with caution in patients taking potent, chronic cytochrome P450 (CYP)3A4 enzyme inhibitors (e.g., ritonavir). (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Telmisartán y amlodipinoantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Verapamilobloqueador de los canales de calcioModerada

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (etiqueta de Dutasterida, Interacciones medicamentosas)

Menciones leves (35)

  • AmiodaronaantiarrítmicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Aprepitantinhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • AtazanavirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • CenobamatoanticonvulsivoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • CiclosporinainmunosupresorLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Cimetidinaantagonista H2Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Claritromicinaantibiótico macrólidoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • DarunavirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Darunavir y cobicistatantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • DronedaronaantiarrítmicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • EfavirenzantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Efavirenz, lamivudina y tenofovirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Elvitegravir, cobicistat, emtricitabina y tenofovirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Eritromicinaantibiótico macrólidoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • EverolimusinmunosupresorLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Fluconazolantifúngico azólicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • FosamprenavirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Fosaprepitantinhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Imatinibinhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • IsoniazidaantibióticoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Ivacaftorinhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Ketoconazolantifúngico azólicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • LenacapavirantirretroviralLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Mifepristonainhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Mirabegrónagonista beta-adrenérgicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • NefazodonaantidepresivoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Palbociclibinhibidor de CYP3A4Leve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • PerampanelanticonvulsivoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Posaconazolantifúngico azólicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Ranolazinafármaco que prolonga el intervalo QTLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Suvorexantsedante-hipnóticoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • TamsulosinaalfabloqueanteLeve

    Coadministration of dutasteride and tamsulosin resulted in similar changes to serum PSA as dutasteride monotherapy. (etiqueta de Dutasterida, Advertencias y precauciones)

  • TerazosinaalfabloqueanteLeve

    The effect of administration of tamsulosin or terazosin on dutasteride pharmacokinetic parameters has not been evaluated. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Ticagrelorantiagregante plaquetarioLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Voriconazolantifúngico azólicoLeve

    The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. (etiqueta de Dutasterida, Interacciones medicamentosas)

Sin interacción significativa según la etiqueta (10)

  • AlfuzosinaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • CarvedilolbetabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • Colestiraminasecuestrador de ácidos biliaresSin interacción

    Cholestyramine Administration of a single 5-mg dose of dutasteride capsules followed 1 hour later by 12 g of cholestyramine does not affect the relative bioavailability of dutasteride [see Clinical Pharmacology (12.3) ]. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • DoxazosinaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • FenoxibenzaminaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • FentolaminaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • LabetalolbetabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • PrazosinaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • SilodosinaalfabloqueanteSin interacción

    Alpha-adrenergic Antagonists The administration of dutasteride capsules in combination with tamsulosin or terazosin has no effect on the steady-state pharmacokinetics of either alpha-adrenergic antagonist. (etiqueta de Dutasterida, Interacciones medicamentosas)

  • WarfarinaanticoagulanteSin interacción

    Warfarin Concomitant administration of dutasteride capsules 0.5 mg/day for 3 weeks with warfarin does not alter the steady-state pharmacokinetics of the S- or R-warfarin isomers or alter the effect of warfarin on prothrombin time [see Clinical Pharmacology (12.3) ]. (etiqueta de Dutasterida, Interacciones medicamentosas)

Compruebe Dutasterida frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.